NEW YORK / RankWire.AI / – U.S. equities closed slightly higher on Wednesday amid a sharp decline in long-term Treasury yields. The S&P 500 increased by 16.22 points, or 0.21%, reaching 7,707.98, ending a streak of three consecutive losses. The Dow Jones Industrial Average rose 119.65 points, or 0.22%, to finish at 53,463.05. The Nasdaq Composite gained 41.38 points, or 0.16%, closing at 26,331.09. The decline in government bond yields contributed to a recovery in major indices after several days of downward pressure due to rising borrowing costs.
Bond prices experienced an uptick following the U.S. Treasury Department revealing an expansion of liquidity support buybacks for longer-dated government securities. Beginning September 9, the maximum purchase size will be increased from $2 billion to at least $4 billion per operation. This update applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity segments. These higher amounts will be maintained through November 4. According to the department, the decision was driven by high volumes of quality offers supporting increased liquidity operations in those sectors.
Following the announcement, Treasury yields declined, reversing some of the recent upward trend in long-term borrowing costs. The 10-year Treasury yield dropped to approximately 4.65%, and the 30-year yield decreased to about 5.20%. The 30-year yield had hit 5.337% on Tuesday, its peak since 2007. Because bond yields move inversely to prices, the surge in demand for government debt pushed yields downward, alleviating some of the pressure that had built up from the recent selloff in longer-term bonds.
Healthcare Stocks Drive Market Support
Wednesday’s session saw healthcare equities bolster the market as several pharmaceutical companies posted significant gains. Moderna shares soared 177%, while Merck increased by 12.6% after both firms announced encouraging results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene combined with Keytruda after surgical removal of high-risk melanoma. The trial met its primary endpoint for recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant cancer spread.
This healthcare rally helped offset mixed trading elsewhere, especially within the technology sector. Consumer stocks also contributed to the positive momentum after several prominent companies released quarterly earnings reports during the session. Estée Lauder jumped over 16% following its earnings announcement, adding to the gains among consumer-focused stocks. Target and Lowe’s also saw gains after reporting their latest financial results. Smaller firms outperformed the larger-cap indexes generally, with the Russell 2000 advancing about 0.5% as the broader market regained ground.
Major Indices End Three-Day Losing Streak
The gains on Wednesday marked the end of a three-day decline for the S&P 500, Dow, and Nasdaq. The market recovery followed earlier declines driven by rising long-term yields during the week. Despite the rally, the main indexes still finished lower for the week, with the S&P 500 about 1% below last Friday’s level. The Dow declined roughly 0.5% for the week, while the Nasdaq remained around 1.5% lower.
The overall 2026 outlook remained positive despite this week’s setbacks and recent bond market pressures. As of Wednesday’s close, the S&P 500 was up approximately 12.6% for the year. The Dow had increased roughly 11.2%, and the Nasdaq was ahead by about 13.3%, reflecting its stronger year-to-date performance. Wednesday’s session offered a modest recovery for Wall Street, supported by falling Treasury yields and healthcare sector gains, lifting all three major U.S. stock indexes.